A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
about
A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A multicenter, randomized, pla ...... femoral junction incompetence.
@ast
A multicenter, randomized, pla ...... femoral junction incompetence.
@en
type
label
A multicenter, randomized, pla ...... femoral junction incompetence.
@ast
A multicenter, randomized, pla ...... femoral junction incompetence.
@en
prefLabel
A multicenter, randomized, pla ...... femoral junction incompetence.
@ast
A multicenter, randomized, pla ...... femoral junction incompetence.
@en
P2093
P2860
P356
P1433
P1476
A multicenter, randomized, pla ...... femoral junction incompetence.
@en
P2093
Kathleen Gibson
Lowell Kabnick
Varithena® 013 Investigator Group
P2860
P304
P356
10.1177/0268355516635386
P577
2016-03-24T00:00:00Z